<?xml version="1.0" encoding="UTF-8"?>
<p id="p0460">The HTLV-1 
 <italic>Tax</italic> gene can decrease Th1-like antiviral signaling pathways both by modulating the suppressor of cytokine signaling 1 (SOCS1)
 <xref rid="bib119" ref-type="bibr">
  <sup>119</sup>
 </xref> and also through the aryl hydrocarbon receptor protein (AIP) that binds to interferon regulatory factor 7 (IRF7), thus decreasing Type I interferon (IFN-α/β) expression.
 <xref rid="bib120" ref-type="bibr">
  <sup>120</sup>
 </xref> HTLV-1 modifies the behavior of CD4
 <sup>+</sup> T cells and alters their cytokine production. HTLV-1 is clinically associated with adult T cell leukemia/lymphoma (ATL), and tropical spastic paraparesis/HTLV-1-associated myelopathy (PET/HAM)
 <xref rid="bib121" ref-type="bibr">
  <sup>121</sup>
 </xref> and can cause autoimmune disease, such as rheumatoid arthritis, systemic lupus erythematosis, and Sjögren's syndrome.
 <xref rid="bib117" ref-type="bibr">117</xref>, 
 <xref rid="bib118" ref-type="bibr">118</xref>, 
 <xref rid="bib119" ref-type="bibr">119</xref>, 
 <xref rid="bib120" ref-type="bibr">120</xref>
</p>
